Saturday, July 11, 2026

Drug profile · INN

piperonyl butoxide

piperonyl butoxide (RID MOUSSE) is a cytochrome p450 inhibitor. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — piperonyl butoxide
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

piperonyl butoxide (RID MOUSSE) is a cytochrome p450 inhibitor. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN piperonyl butoxide
Brand RID MOUSSE
Mechanism Cytochrome P450 inhibitor
Target Cytochrome P450
Route TOPICAL
Formulation AEROSOL

Mechanism of action

Cytochrome P450 inhibitor

Primary target: Cytochrome P450

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. ritonavir Antiinfectives for systemic use (J05)
  2. cobicistat Various (V03)
  3. metyrapone Cytochrome P450 11B1, mitochondrial inhibitor
  4. osilodrostat phosphate Cytochrome P450 11B1 inhibitor

Frequently asked questions

What is piperonyl butoxide?

piperonyl butoxide (RID MOUSSE) is a cytochrome p450 inhibitor. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for piperonyl butoxide?

RID MOUSSE is a marketed brand name for piperonyl butoxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of piperonyl butoxide?

piperonyl butoxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.